BIOLOGIC DRUGS 

Get new perspectives on protein-protein interactions with biological compounds.

solution2.png

3D structures of biologicals binding to their target complex

ATEM’s cryo-EM technology now enables the routine structure determination of high-affinity protein-protein interactions - in particular for monoclonal antibodies (mAbs, Fabs) or peptides.

Functional dynamics insights

Probe the impact on target dynamics during the binding of your biological compound(s) and obtain unprecedented functional insights on how your drug candidates mechanistically interfere with your target complex.

The new gold standard in efficient and precise 3D epitope mapping

No matter whether required for patent applications or rational drug design – we create high-resolution and unambiguous epitope maps that feature your target complexes in conjunction with a palette of mAb/Fab candidates.

LET US KNOW ABOUT 
YOUR CHALLENGES.

Our Experts are always happy to discuss how we can support you with our cryo-EM focused solutions.